Merck & Company, Inc. vs Organigram Global Inc. — Stock Comparison

MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
vs
OGI
Organigram Global Inc.
$1.42
▲ 0.71%
Q·Score Winner
Merck & Company, Inc.
MRK6.7/10vs 6.1/10

Q·Score Breakdown

6.7
Neutral
Overall
6.1
Neutral
6.2
Quality
3.6
7
Health
8.4
6.2
Growth
6.7
7.2
Valuation
4.9
7.1
Sentiment
8.3
MRK

Forward P/E of 11.5× is low relative to sector peers.

OGI

Clean balance sheet with low leverage (0.0× debt-to-equity).

low return on equity (5%).

Analyst Consensus

BUY
Target $129.74 (+15.7%)
27 analysts
BUY
0 analysts

Fundamentals

MRK
OGI
31.5×
Trailing P/E
12.9×
11.5×
Forward P/E
59.2×
13.6%
Profit Margin
6.5%
76.6%
Gross Margin
35.6%
ROE
4.6%
4.9%
Revenue Growth
48.7%
Earnings Growth
0.28
Beta
1.87
Price / Book
$277.0B
Market Cap
$200M
$73 – $125
52-Week Range
$1 – $2

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →